Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$8.90 USD
-0.34 (-3.68%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $8.90 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Balance Sheet
Fiscal Year End for Pediatrix Medical Group, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 178 | 103 | 487 | 1,229 | 187 |
Receivables | 280 | 297 | 316 | 242 | 499 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 26 | 28 | 37 | 79 | 45 |
Total Current Assets | 483 | 428 | 841 | 1,549 | 732 |
Net Property & Equipment | 76 | 73 | 70 | 76 | 94 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 103 | 106 | 88 | 54 | 162 |
Intangibles | 1,405 | 1,551 | 1,527 | 1,505 | 2,985 |
Deposits & Other Assets | 82 | 123 | 131 | 107 | 90 |
Total Assets | 2,220 | 2,348 | 2,723 | 3,348 | 4,146 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 351 | 374 | 394 | 423 | 512 |
Current Portion Long-Term Debt | 15 | 15 | 2 | 2 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 2 | 16 | 11 | 0 | 7 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 389 | 427 | 427 | 444 | 542 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 34 | 34 | 41 | 62 | 58 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 618 | 636 | 1,002 | 1,743 | 1,730 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 282 | 315 | 313 | 311 | 250 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,371 | 1,456 | 1,826 | 2,600 | 2,647 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 1,000 | 984 | 1,050 | 1,029 | 988 |
Retained Earnings | -149 | -89 | -155 | -286 | 510 |
Other Equity | -2 | -4 | 2 | 4 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 849 | 892 | 897 | 748 | 1,499 |
Total Liabilities & Shareholder's Equity | 2,220 | 2,348 | 2,723 | 3,348 | 4,146 |
Total Common Equity | 849 | 892 | 897 | 748 | 1,499 |
Shares Outstanding | 84.00 | 83.00 | 86.40 | 85.60 | 84.30 |
Book Value Per Share | 10.11 | 10.74 | 10.38 | 8.74 | 17.78 |
Fiscal Year End for Pediatrix Medical Group, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 178 | 125 | 104 | 103 |
Receivables | NA | 280 | 277 | 271 | 279 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 26 | 18 | 23 | 27 |
Total Current Assets | NA | 483 | 421 | 398 | 409 |
Net Property & Equipment | NA | 76 | 75 | 73 | 73 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 103 | 103 | 102 | 103 |
Intangibles | NA | 1,405 | 1,548 | 1,549 | 1,550 |
Deposits & Other Assets | NA | 82 | 108 | 117 | 119 |
Total Assets | NA | 2,220 | 2,326 | 2,306 | 2,320 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 351 | 303 | 278 | 227 |
Current Portion Long-Term Debt | NA | 15 | 15 | 15 | 15 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 2 | 11 | 6 | 22 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 389 | 350 | 320 | 284 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 34 | 41 | 38 | 33 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 618 | 622 | 666 | 743 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 297 | 296 | 307 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 1,371 | 1,358 | 1,363 | 1,410 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 1,000 | 996 | 992 | 987 |
Retained Earnings | NA | -149 | -25 | -47 | -75 |
Other Equity | NA | -2 | -4 | -4 | -3 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 849 | 968 | 942 | 910 |
Total Liabilities & Shareholder's Equity | NA | 2,220 | 2,326 | 2,306 | 2,320 |
Total Common Equity | 0 | 849 | 968 | 942 | 910 |
Shares Outstanding | 84.00 | 84.00 | 84.00 | 83.90 | 83.70 |
Book Value Per Share | 0.00 | 10.11 | 11.52 | 11.23 | 10.87 |